News + Publications
When Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest
10 October 2022
Even before COVID-19 vaccines were available, different interest levels in vaccination across the US were noted.
Read More
Sinopharm advances in Fortune Global 500
06 September 2022
The UAE ambassador to China, His Excellency Dr. Ali Obaid Al Dhaheri congratulated SINOPHARM, a Hayat Biotech shareholder, for advancing in the Fortune Global 500 list of the largest companies in the world, from ranking 109th in 2021 to the 80th rank this year.
Read More
Where Science Meets Art
06 September 2022
Leading a new initiative to expand our customer base, we signed a partnership with the Louvre Museum.
Read More
UAE Delegation to Pakistan
06 September 2022
Hayat Biotech continues to explore global strategic partnerships in its relentless pursuit to further expand our product portfolio.
Read More
Abu Dhabi-based G42 launches $10bn tech investment fund
05 September 2022
The G42 Expansion Fund’s investment priorities will span across computing and communications technologies, intelligent mobility, clean tech and renewables, digital infrastructures, fintech, healthcare and life sciences
Read More